Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.32 USD | -2.39% | -4.88% | +168.66% |
May. 10 | Wedbush Adjusts Vera Therapeutics' PT to $32 From $34, Keeps Neutral Rating | MT |
May. 09 | Vera Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 51
Managers
Managers | Title | Age | Since |
---|---|---|---|
Marshall Fordyce
FOU | Founder | 50 | 16-04-30 |
Sean Grant
DFI | Director of Finance/CFO | 39 | 21-07-11 |
Kerry Cooper
CTO | Chief Tech/Sci/R&D Officer | - | 23-05-03 |
Tom Doan
COO | Chief Operating Officer | 52 | 20-02-29 |
Chief Tech/Sci/R&D Officer | 56 | 23-01-07 | |
Julien Capers
LAW | General Counsel | - | 22-08-31 |
Joseph Young
AUD | Comptroller/Controller/Auditor | 52 | 21-02-28 |
Lauren Frenz
PRN | Corporate Officer/Principal | 39 | 20-03-31 |
Kelly Rauber
HRO | Human Resources Officer | - | 22-09-30 |
Corporate Officer/Principal | 58 | 23-01-07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Beth Seidenberg
BRD | Director/Board Member | 67 | 16-05-31 |
Chairman | 63 | 22-05-23 | |
Patrick Enright
BRD | Director/Board Member | 62 | 20-10-31 |
Maha Katabi
BRD | Director/Board Member | 50 | 20-09-30 |
Andrew Cheng
BRD | Director/Board Member | 57 | 17-04-30 |
Scott Morrison
BRD | Director/Board Member | 66 | 20-03-31 |
Marshall Fordyce
FOU | Founder | 50 | 16-04-30 |
Kimball Hall
BRD | Director/Board Member | 58 | 21-12-13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 54,452,029 | 50,125,194 ( 92.05 %) | 0 | 92.05 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+168.66% | 2.26B | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+47.47% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- VERA Stock
- Company Vera Therapeutics, Inc.